wsbdaily | Thu, 21 Oct 2021 07:34:43 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Cassava Sciences, Inc.(SAVA)
Cassava Sciences, Inc.
7801 North Capital of Texas Highway
Suite 260
Austin, TX 78731
United States
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc.... Read More
Summary & Charts
| Price | $ 47.50 | -2.66 (-5.31%) |
| Day's Range | $ 47.23 - 51.35 | |
| Previous Close | $ 50.16 | |
| Market Cap | $ 1.39B USD | |
| Short Interest % | N/A | |
| Float | N/A | |
| Outstanding | N/A |
| Exchange | NasdaqGS | |
| Industry | Biotechnology | |
| Sector | Healthcare | |
| Volume | 3.75M | |
| Avg. Volume (20 day) | 6.72M | |
| Rel. Volume (20 day) | 0.56 | |
| Rel. Volume (3 month) | 0.45 | |
| Rating | B+ | Buy |
| DCF | N/A | Strong Buy |
| Debt/Equity | 1.75 % | Neutral |
| ROE | -9.74 % | Neutral |
| ROA | -5.84 % | Neutral |
| P/E | -115.61 % | Strong Sell |
| P/B | 6.86 % | Strong Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2021 | $ 50.08 | $ 51.35 | $ 47.23 | $ 47.50 | -2.66 | 3,753,098 | 0.56 | 0.45 | 2 |
| Oct 18, 2021 | $ 49.99 | $ 52.64 | $ 49.17 | $ 50.16 | +0.47 | 3,354,036 | 0.49 | 0.41 | 2 |
| Oct 15, 2021 | $ 54.00 | $ 54.00 | $ 49.60 | $ 49.69 | -3.68 | 3,763,909 | 0.55 | 0.47 | 6 |
| Oct 14, 2021 | $ 53.09 | $ 57.20 | $ 52.25 | $ 53.37 | -1.62 | 3,608,589 | 0.52 | 0.45 | 21 |
| Oct 13, 2021 | $ 52.41 | $ 56.59 | $ 50.55 | $ 54.99 | +3.11 | 3,678,948 | 0.52 | 0.46 | 77 |
| Oct 12, 2021 | $ 51.31 | $ 52.51 | $ 50.14 | $ 51.88 | +0.80 | 2,131,134 | 0.30 | 0.27 | 2 |
| Oct 11, 2021 | $ 51.19 | $ 52.11 | $ 47.79 | $ 51.08 | -0.41 | 3,855,258 | 0.52 | 0.49 | 1 |
| Oct 08, 2021 | $ 53.52 | $ 54.77 | $ 51.12 | $ 51.49 | -2.13 | 2,233,680 | 0.30 | 0.29 | 3 |
| Oct 07, 2021 | $ 52.94 | $ 54.56 | $ 50.25 | $ 53.62 | +1.11 | 3,950,745 | 0.51 | 0.52 | 4 |
| Oct 06, 2021 | $ 56.88 | $ 59.98 | $ 52.13 | $ 52.51 | -4.66 | 6,102,004 | 0.77 | 0.80 | 9 |
| Oct 05, 2021 | $ 54.95 | $ 57.47 | $ 54.74 | $ 57.17 | +2.86 | 3,384,973 | 0.42 | 0.45 | 6 |
| Oct 04, 2021 | $ 59.41 | $ 61.67 | $ 54.24 | $ 54.31 | -6.21 | 4,190,497 | 0.51 | 0.55 | 5 |
| Oct 01, 2021 | $ 61.45 | $ 61.93 | $ 56.64 | $ 60.52 | -1.56 | 4,193,724 | 0.45 | 0.55 | 21 |
| Sep 30, 2021 | $ 63.00 | $ 63.52 | $ 60.04 | $ 62.08 | -0.06 | 4,274,020 | 0.45 | 0.55 | 10 |
| Sep 29, 2021 | $ 66.00 | $ 67.58 | $ 60.07 | $ 62.14 | -2.85 | 6,966,585 | 0.72 | 0.89 | 5 |
| Sep 28, 2021 | $ 65.54 | $ 67.88 | $ 61.68 | $ 64.99 | -3.54 | 8,796,599 | 0.87 | 1.13 | 5 |
| Sep 27, 2021 | $ 62.14 | $ 70.27 | $ 61.90 | $ 68.53 | +6.59 | 10,942,666 | 1.05 | 1.41 | 37 |
| Sep 24, 2021 | $ 59.40 | $ 66.68 | $ 58.15 | $ 61.94 | +1.82 | 15,004,137 | 1.24 | 1.94 | 24 |
| Sep 23, 2021 | $ 50.37 | $ 62.67 | $ 50.33 | $ 60.12 | +7.81 | 16,498,083 | 1.31 | 2.16 | 32 |
| Sep 22, 2021 | $ 59.03 | $ 60.60 | $ 48.83 | $ 52.31 | -0.55 | 23,777,666 | 1.80 | 3.17 | 37 |
News
The latest news about Cassava Sciences, Inc. (SAVA).
Accesswire | 2021-10-15 05:45:00
NEW YORK, NY / ACCESSWIRE / October 15, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.
Newsfile Corp | 2021-10-14 16:08:00
Los Angeles, California--(Newsfile Corp. - October 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cassava Sciences, Inc. ("Cassava" or "the Company") (NASDAQ: SAVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between September 14, 2020 and August 27, 2021, inclusive...
Accesswire | 2021-10-13 17:30:00
NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.
Newsfile Corp | 2021-10-13 14:32:00
San Francisco, California--(Newsfile Corp. - October 13, 2021) - Hagens Berman urges Cassava Sciences, Inc. (NASDAQ: SAVA) investors with significant losses to submit your losses now.Class Period: Sept. 14, 2020 - Aug. 27, 2021Lead Plaintiff Deadline: Oct. 26, 2021Visit: www.hbsslaw.com/investor-fraud/SAVA Contact An Attorney Now: SAVA@hbsslaw.com 844-916-0895Cassava Sciences, Inc. (SAVA) Securities Fraud Class Action: The complaint alleges that Defendants made false and misleading statements and omissions concer
PRNewsWire | 2021-10-13 12:00:00
LOS ANGELES, Oct. 13, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA). Class Period: September 14, 2020 and August 27, 2021 Lead Plaintiff Deadline: October 26, 2021 If you wish to serve as lead plaintiff of the Cassava lawsuit, you can submit your contact information at https://www.glancylaw.com/cases/cassava-sciences-inc/.
Newsfile Corp | 2021-10-12 20:01:00
Radnor, Pennsylvania--(Newsfile Corp. - October 12, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Cassava Sciences, Inc. (NASDAQ: SAVA) ("Cassava") on behalf of those who purchased or acquired Cassava securities betweeen September 14, 2020 and August 27, 2021, inclusive (the "Class Period").CLICK HERE TO SUBMIT YOUR CASSAVA LOSSESLEAD PLAINTIFF DEADLINE: October 26, 2021CLASS PERIOD: ...
Accesswire | 2021-10-12 17:15:00
NEW YORK, NY / ACCESSWIRE / October 12, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2021-11-08 | BMO | -0.15 | -- | -- | -- | -- | -- |
| 2021-08-03 | BMO | -0.11 | -0.13 | 18.18% | -- | -- | -- |
| 2021-04-21 | BMO | -0.1 | -0.09 | 10% | -- | -- | -- |
| 2020-11-09 | BMO | -0.07 | -0.06 | 14.29% | -- | -- | -- |
| 2020-08-12 | BMO | -0.06 | -0.05 | 16.67% | -- | -- | -- |
| 2020-05-06 | BMO | -- | -- | -- | -- | -- | -- |
| 2020-03-26 | BMO | -0.13 | -0.08 | 38.47% | -- | -- | -- |
| 2019-10-29 | BMO | -0.13 | -0.04 | 69.24% | -- | -- | -- |
Due Diligences
These posts should include more in-depth research by the poster about the specific company, sector or trade idea. Including any sources and citations.
$SAVA Cassava Sciences: Backgrounder for those curious about the story
I sometimes adopt a single stock that I find to be an interesting story to follow. Here is a summary of why I find SAVA to be my current one. # tl;dr * Alzheimer’s common, and lacks a cure. * SAVA is a high risk, high IV, biotech stock: an all-in play on their Alzheimer drug candidate. * SAVA was... Read More
SAVA. Cause. More. Wrinkle.
TLDR: At the end of the post. **Associate Professor of Internal Medicine and, more importantly, a certified SAVAge here:** First, I've sent my LinkedIn profile, institutional email, and Institutional Profile to the mods to verify my credentials. Verification of credentials was a big concern... Read More
SAVA is primed for a strong MOVE
Shorts are getting scared on SAVA. Data was solid yesterday but stock price got manipulated down by shorts. **The BEST RESULTS EVER FOR AN ALZHEIMERS DRUG**. More news is coming with the company enlisting patients for Phase 3 Trials. Bio-data to be released from the 12mon data report. Lawsuit deadl... Read More
Top Discussions
These are the top discussions over the last 24-hours that mention the SAVA stock ticker symbol.
Unusual Option Activity
Option contracts that are trading at a significantly higher volume relative to the contract's open interest. These might provide some insight into what "smart money" is doing with large volume orders.
| Type | Strike | Exp Date | DTE | Bid | Ask | Last | Volume | Open Interest | Vol/OI | IV |
|---|---|---|---|---|---|---|---|---|---|---|
| CALL | $ 52.00 | 10/14/21 | 0 | $ 3.60 | $ 4.10 | $ 3.92 | 566 | 445 | 1.27 | 1.27% |
| CALL | $ 56.00 | 10/14/21 | 0 | $ 1.30 | $ 1.60 | $ 1.40 | 553 | 223 | 2.48 | 1.17% |
| CALL | $ 47.00 | 10/21/21 | 7 | $ 7.80 | $ 10.80 | $ 6.90 | 44 | 20 | 2.20 | 1.30% |
| CALL | $ 53.00 | 10/21/21 | 7 | $ 4.50 | $ 5.20 | $ 4.90 | 154 | 113 | 1.36 | 1.12% |
| CALL | $ 55.00 | 10/21/21 | 7 | $ 3.60 | $ 4.00 | $ 3.80 | 502 | 202 | 2.49 | 1.11% |
| CALL | $ 66.00 | 10/21/21 | 7 | $ 0.80 | $ 1.05 | $ 1.00 | 100 | 20 | 5.00 | 1.17% |
| CALL | $ 100.00 | 10/21/21 | 7 | $ 0.10 | $ 0.15 | $ 0.15 | 128 | 45 | 2.84 | 1.79% |
| PUT | $ 39.00 | 10/21/21 | 7 | $ 0.25 | $ 0.35 | $ 0.30 | 264 | 74 | 3.57 | 1.45% |
| PUT | $ 46.00 | 10/21/21 | 7 | $ 0.85 | $ 1.05 | $ 1.05 | 90 | 54 | 1.67 | 1.24% |
| PUT | $ 48.00 | 10/21/21 | 7 | $ 0.90 | $ 1.60 | $ 1.35 | 94 | 74 | 1.27 | 1.17% |
| PUT | $ 52.00 | 10/21/21 | 7 | $ 2.40 | $ 2.60 | $ 2.75 | 88 | 50 | 1.76 | 1.14% |
| PUT | $ 53.00 | 10/21/21 | 7 | $ 2.80 | $ 3.10 | $ 2.95 | 86 | 62 | 1.39 | 1.14% |
| PUT | $ 54.00 | 10/21/21 | 7 | $ 3.10 | $ 3.50 | $ 3.35 | 104 | 52 | 2.00 | 1.11% |
| PUT | $ 55.00 | 10/21/21 | 7 | $ 3.50 | $ 4.00 | $ 3.86 | 172 | 113 | 1.52 | 1.09% |
| CALL | $ 48.00 | 10/28/21 | 14 | $ 7.80 | $ 11.30 | $ 8.90 | 93 | 30 | 3.10 | 1.25% |
| CALL | $ 49.00 | 10/28/21 | 14 | $ 7.60 | $ 9.20 | $ 6.80 | 133 | 64 | 2.08 | 1.11% |
| CALL | $ 54.00 | 10/28/21 | 14 | $ 5.10 | $ 6.70 | $ 5.60 | 100 | 55 | 1.82 | 1.19% |
| CALL | $ 57.00 | 10/28/21 | 14 | $ 4.20 | $ 4.90 | $ 4.60 | 47 | 32 | 1.47 | 1.18% |
| CALL | $ 62.00 | 10/28/21 | 14 | $ 2.75 | $ 3.30 | $ 2.85 | 32 | 11 | 2.91 | 1.21% |
| CALL | $ 67.00 | 10/28/21 | 14 | $ 1.35 | $ 2.25 | $ 1.89 | 61 | 22 | 2.77 | 1.18% |
| PUT | $ 39.00 | 10/28/21 | 14 | $ 0.70 | $ 1.90 | $ 0.95 | 39 | 16 | 2.44 | 1.64% |
| PUT | $ 51.00 | 10/28/21 | 14 | $ 3.50 | $ 3.80 | $ 3.80 | 302 | 56 | 5.39 | 1.23% |
| PUT | $ 52.00 | 10/28/21 | 14 | $ 4.00 | $ 4.30 | $ 4.15 | 308 | 100 | 3.08 | 1.24% |
| PUT | $ 53.00 | 10/28/21 | 14 | $ 4.30 | $ 6.70 | $ 4.67 | 48 | 34 | 1.41 | 1.44% |
| PUT | $ 54.00 | 10/28/21 | 14 | $ 4.70 | $ 5.70 | $ 5.30 | 68 | 10 | 6.80 | 1.25% |
| PUT | $ 67.00 | 10/28/21 | 14 | $ 13.20 | $ 14.80 | $ 17.40 | 21 | 13 | 1.62 | 1.23% |
| CALL | $ 54.00 | 11/04/21 | 21 | $ 6.40 | $ 7.90 | $ 7.31 | 98 | 19 | 5.16 | 1.22% |
| CALL | $ 55.00 | 11/04/21 | 21 | $ 6.60 | $ 7.50 | $ 6.84 | 327 | 27 | 12.11 | 1.29% |
| CALL | $ 60.00 | 11/04/21 | 21 | $ 4.70 | $ 5.00 | $ 4.80 | 149 | 64 | 2.33 | 1.23% |
| PUT | $ 48.00 | 11/04/21 | 21 | $ 2.45 | $ 5.50 | $ 4.48 | 1,010 | 17 | 59.41 | 1.35% |
| CALL | $ 175.00 | 01/20/22 | 98 | $ 0.75 | $ 1.45 | $ 1.47 | 102 | 50 | 2.04 | 1.29% |
| CALL | $ 145.00 | 01/19/23 | 462 | $ 11.90 | $ 14.00 | $ 13.80 | 94 | 65 | 1.45 | 1.13% |
Last Updated: Wed, 13 Oct 2021 23:27 EST
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Fri, 30 Jul 2021 12:00 EST
@wsbdaily
wsbdaily